Press Secretary Karine Jean-Pierre’s Response to the Southern District of Ohio’s Ruling on Medicare Drug Price Negotiation

By Better Today On Sep 29, 2023

TL/DR –

For decades, Big Pharma has prevented Medicare from negotiating lower drug prices, a situation changed by the passing of the Inflation Reduction Act by President Biden and Congressional Democrats. A recent ruling from the Southern District of Ohio has confirmed that Medicare can now negotiate lower prices for senior prescriptions. As a result of this legislation and program, millions of people with Medicare will see a decrease in the prices of prescriptions for a number of common conditions like heart failure, blood clots, diabetes, and arthritis.

Big Pharma’s grip on Medicare pricing finally loosened

For years, Big Pharma kept Medicare from negotiating lower drug prices, benefiting from massive profits while seniors grappled with high healthcare costs. The Inflation Reduction Act, passed by President Biden and Congressional Democrats, marks a significant shift, despite unanimous opposition from Congressional Republicans.

A recent ruling from the Southern District of Ohio affirms Medicare’s right to negotiate lower prices. The Biden-Harris Administration remains committed to this cause, asserting there’s no constitutional barrier preventing Medicare from negotiating drug prices.

Lower costs for costly treatments on the horizon

Thanks to the Inflation Reduction Act, Medicare beneficiaries will continue to see a decrease in prescription drug costs for treatments of common conditions such as heart disease, blood clots, diabetes, and arthritis.

There’s no justification for Americans having to pay two to three times more for prescription drugs than citizens in other developed nations. The Biden Administration will continue to battle high healthcare costs for American families, undeterred by the obstacles presented by Republicans and Big Pharma.